急性心肌梗死尿激酶静脉溶栓的临床评价
 |
| 第1页 |
参见附件。
【摘要】目的评价尿激酶在急性心肌梗死静脉溶栓中的疗效及安全情况。方法将72例患者随机分为治疗组36例和对照组36例，在常规治疗基础上，治疗组进行尿激酶溶栓治疗，对照组给予硝酸甘油和肝素钠治疗。结果两组组间血管再通率差异有显著性(P<005)。结论在常规治疗基础上加用尿激酶能更有效地控制AMI，且尿激酶溶栓时间越早，再通率越高，副作用小，值得推广运用。
【关键词】急性心肌梗死；尿激酶；溶栓治疗
The clinical evaluation of urokinase thrombolytic therapy in the treatment of acute myocardial infarction SUN Hong-bo,ZHANG Xiao-hui.The Central Hospital of Xinxiang,Xinxiang 453000,China
【Abstract】ObjectiveTo evaluate the clinical effects of urokinase thrombolytic therapy in the treatment of acute myocardial infarction.Methods72 patients with AMI were randomly divided into two groups,the treatment group (36 cases) and the control group(36 cases),on the basis of conventional therapy,the treatment group received urokinase thrombolytic therapy treatment,the control group received nitroglycerin and Heparin Sodium therapy.ResultsThere was significant difference between the two groups vessel recanalisation(P<005).ConclusionUrokinase Thrombolytic Therapy can control AMI more effectively On the basis of conventional therapy ......
您现在查看是摘要介绍页，详见PDF附件。